China NMPA Product Recall - Liquid dressing

The National Medical Products Administration (NMPA) in China announced on July 26, 2023, a voluntary Class III recall initiated by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd. This action pertains to liquid dressings manufactured by Smith & Nephew Medical Limited (NMPA Registration No. 20222140270). The recall stems from reported issues of an unpleasant odor and the potential for minor skin irritation associated with the affected products. Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd., as the entity reporting the recall, is managing the process in accordance with NMPA regulations. While specific inspection dates are not provided in this announcement, the recall itself serves as a regulatory response to product quality concerns. The Class III classification indicates a situation where use of, or exposure to, a violative product is not likely to cause adverse health consequences. Detailed information regarding the specific models, specifications, and batch numbers of the recalled liquid dressings is available in an accompanying "Medical Device Recall Event Report Form." This recall highlights the manufacturer's responsibility and the NMPA's oversight in ensuring the safety and quality of medical devices within China.